Today on Tap: President Biden’s NIH rejects a petition to seize the patent of an unaffordable prescription drug.
Big Pharma
The American Rescue Plan’s Hidden Triumphs
Medicaid expansion in North Carolina and Eli Lilly’s insulin price cuts are largely due to the March 2021 law.
A Small Victory Over Big Pharma
Today on TAP: Eli Lilly announces insulin price caps, but keep an eye on the footnotes.
Breaking Up (With China) Is Hard to Do
In the absence of more attention to the supply chain, the U.S. is becoming even more reliant on Beijing—and ‘friendshoring’ often increases that dependence.
A Pitched Battle on Corporate Power
Biden’s expansive executive order seeks to restore competition in the economy. It’s been a long, slow road to get the whole government on board—but there are some formidable gains.
Moderna’s COVID Vaccine Price Hike Reveals Government’s Failure
The U.S. co-invented the mRNA vaccine. So why doesn’t it act like it?
Senate Democrats Finally Control Committee Majorities. What Now?
Here are nine practical and urgent suggestions.
Ashish Jha and the Moral Horror of Too Little Progress
The new position of White House pandemic preparedness director requires boldness on intellectual property.
Biden Must Wield the Power of the Defense Production Act to Rein In the Tripledemic
America is in for a rough winter, but the government can help.
What America Can Learn From Donald Trump’s Greatest Accomplishment
On the COVID-19 vaccines, well, you have to hand it to him.

